Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.

Literature DB >> 16048971

Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.

Nicole J Pultz¹, Usha Stiefel, Curtis J Donskey.

Abstract

In mice, vancomycin and linezolid treatment disrupted the anaerobic intestinal microflora, based on denaturing gradient gel electrophoresis analysis, and promoted colonization by Klebsiella pneumoniae and vancomycin-resistant enterococci. However, the effects varied depending on dose and duration of treatment. Daptomycin treatment did not disrupt the anaerobic microflora or promote either pathogen.

Entities: Chemical Species

Mesh：

Substances：

Year: 2005 PMID： 16048971 PMCID： PMC1196280 DOI： 10.1128/AAC.49.8.3513-3516.2005

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

13 in total

1. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors: C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal: N Engl J Med Date: 2000-12-28 Impact factor: 91.245

2. In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers.

Authors: A L Barry; P C Fuchs; S D Brown
Journal: Antimicrob Agents Chemother Date: 2001-06 Impact factor: 5.191

Review 3. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors: Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal: Antimicrob Agents Chemother Date: 2002-06 Impact factor: 5.191

4. Some laboratory and clinical experiences with a new antibiotic, vancomycin.

Authors: J E GERACI; F R HEILMAN; D R NICHOLS; G T ROSS; W E WELLMAN
Journal: Proc Staff Meet Mayo Clin Date: 1956-10-17

5. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.

Authors: C J Donskey; J A Hanrahan; R A Hutton; L B Rice
Journal: J Infect Dis Date: 1999-08 Impact factor: 5.226

6. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors: E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal: Cancer Chemother Rep Date: 1966-05

7. Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci.

Authors: Brian P Currie; Luciano Lemos-Filho
Journal: Antimicrob Agents Chemother Date: 2004-11 Impact factor: 5.191

8. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora.

Authors: H Lode; N Von der Höh; S Ziege; K Borner; C E Nord
Journal: Scand J Infect Dis Date: 2001

Review 9. Effect of antimicrobial agents on the ecological balance of human microflora.

Authors: A Sullivan; C Edlund; C E Nord
Journal: Lancet Infect Dis Date: 2001-09 Impact factor: 25.071

Review 10. Quinupristin-dalfopristin and linezolid: evidence and opinion.

Authors: George M Eliopoulos
Journal: Clin Infect Dis Date: 2003-01-31 Impact factor: 9.079

16 in total

1. Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats.

Authors: Anne-Sylvie Kesteman; Agnès Perrin-Guyomard; Michel Laurentie; Pascal Sanders; Pierre-Louis Toutain; Alain Bousquet-Mélou
Journal: Antimicrob Agents Chemother Date: 2010-05-10 Impact factor: 5.191

2. High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous β-Lactams.

Authors: Eva M González-Barberá; Jaime Sanz; Ana Djukovic; Alejandro Artacho; Iván Peñaranda; Beatriz Herrera; María José Garzón; Miguel Salavert; José Luis López-Hontangas; Karina B Xavier; Bernhard Kuster; Laurent Debrauwer; Jean-Marc Rolain; Miguel A Sanz; Joao B Xavier; Carles Ubeda
Journal: Antimicrob Agents Chemother Date: 2020-01-27 Impact factor: 5.191

Review 3. Antimicrobials: Strategies for targeting obesity and metabolic health?

Authors: Eileen F Murphy; Siobhan F Clarke; Tatiana M Marques; Colin Hill; Catherine Stanton; R Paul Ross; Robert M O'Doherty; Fergus Shanahan; Paul D Cotter
Journal: Gut Microbes Date: 2012-09-27

4. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.

Authors: Wafa N Al-Nassir; Ajay K Sethi; Yuejin Li; Michael J Pultz; Michelle M Riggs; Curtis J Donskey
Journal: Antimicrob Agents Chemother Date: 2008-04-28 Impact factor: 5.191

5. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.

Authors: Kerin L Tyrrell; Diane M Citron; Yumi A Warren; Helen T Fernandez; C Vreni Merriam; Ellie J C Goldstein
Journal: Antimicrob Agents Chemother Date: 2006-08 Impact factor: 5.191

6. The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.

Authors: N Bourgeois-Nicolaos; T T Nguyen; G Defrance; L Massias; L Alavoine; A Lefort; V Noel; E Senneville; F Doucet-Populaire; F Mentré; A Andremont; X Duval
Journal: Antimicrob Agents Chemother Date: 2014-02-24 Impact factor: 5.191

7. Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.

Authors: Usha Stiefel; Michelle M Nerandzic; Michael J Pultz; Curtis J Donskey
Journal: Antimicrob Agents Chemother Date: 2014-05-27 Impact factor: 5.191